Abstract
Background
The disease burden of patients with severe aortic stenosis is not often explored, while the incidence is increasing and many patients who have an indication for aortic valve replacement are not referred for surgery. We studied the quality of life of 191 patients with severe aortic stenosis, hypothesising that symptomatic patients have a far worse quality of life than the general population, which could enforce the indication for surgery.
Methods
The SF-36v2 Health Survey was completed by 191 consecutive patients with symptomatic or asymptomatic severe aortic stenosis.
Results
Asymptomatic patients (n = 59) had health scores comparable with the general Dutch population but symptomatic patients (n = 132) scored significantly lower across different age categories. Physical functioning, general health and vitality were impaired, as well as social functioning and emotional well-being. There was no relation between degree of stenosis and physical or mental health scores.
Conclusions
Both physical and emotional problems have a major impact on normal daily life and social functioning of symptomatic patients with severe aortic stenosis, regardless of age. If the aortic stenosis is above the ‘severe’ threshold, the degree of stenosis does not predict disease burden. These results encourage to reconsider a conservative approach in symptomatic patients with severe aortic stenosis. Using the SF-36v2 Health Survey together with this study, an individual patient’s quality of life profile can be assessed and compared with the patient group or with the general population. This can assist in decision making for the individual patient.
Similar content being viewed by others
References
Chan KL, Teo K, Dumesnil JG, et al. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306–14.
Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352(23):2389–97.
Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.
Melby SJ, Zierer A, Kaiser SP, et al. Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann Thorac Surg. 2007;83(5):1651–6. discussion 6–7.
Kolh P, Kerzmann A, Honore C, et al. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg. 2007;31(4):600–6.
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012.
Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32(2):148–57.
Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114(5):e84–231.
Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–68.
van Geldorp MW, van Gameren M, Kappetein AP, et al. Therapeutic decisions for patients with symptomatic severe aortic stenosis: room for improvement? Eur J Cardiothorac Surg. 2009;35(6):953–7. discussion 7.
Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. 2006;15(3):312–21.
Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20.
Bouma BJ, van der Meulen JH, van den Brink RB, et al. Variability in treatment advice for elderly patients with aortic stenosis: a nationwide survey in The Netherlands. Heart. 2001;85(2):196–201.
Sundt TM, Bailey MS, Moon MR, et al. Quality of life after aortic valve replacement at the age of >80 years. Circulation. 2000;102(19 Suppl 3):III70–4.
Noyez L, de Jager MJ, Markou AL. Quality of life after cardiac surgery: underresearched research. Interact Cardiovasc Thorac Surg. 2011;13(5):511–5.
Calkins DR, Rubenstein LV, Cleary PD, et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med. 1991;114(6):451–4.
Heuvelman HJ, van Geldorp MW, Kappetein AP, et al. Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: insights from the AVARIJN study. Neth Heart J. 2012. doi:10.1007/s12471-012-0309-3
Ware Jr JE, Kosinski M, Bjorner JB, et al. User’s manual for the SF-36v2 TM health survey. 2nd ed. Lincoln: Quality Metric; 2007.
Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055–68.
Bouma BJ, van Den Brink RB, van Der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999;82(2):143–8.
Wu Y, Jin R, Gao G, et al. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study. J Thorac Cardiovasc Surg. 2007;133(3):608–13.
Wu Y, Grunkemeier GL, Starr A. The value of aortic valve replacement in elderly patients: an economic analysis. J Thorac Cardiovasc Surg. 2007;133(3):603–7.
Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50(20):2018–9.
Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82(6):2111–5.
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.
Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26(13):1309–13.
Sjogren J, Thulin LI. Quality of life in the very elderly after cardiac surgery: a comparison of SF-36 between long-term survivors and an age-matched population. Gerontology. 2004;50(6):407–10.
van Geldorp MWA, Heuvelman HJ, Kappetein AP, et al. The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis. Neth Heart J. 2013;21. doi:10.1007/s12471-012-0362-y
Acknowledgments
The authors would like to thank the patients, cardiologists, echo laboratory staff and secretaries of the following hospitals for their kind cooperation: Havenziekenhuis, Rotterdam; St. Franciscus Gasthuis, Rotterdam; IJsselland Hospital, Capelle aan den IJssel; Vlietland Hospital, Vlaardingen; Albert Schweitzer Hospital, Dordrecht; Medisch Centrum Rijnmond Zuid, Rotterdam; and Erasmus University Medical Center, Rotterdam.
Disclosures
None of the authors have any competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
The questions can be answered after the article has been published in print. You have to log in to: www.cvoi.nl.
Rights and permissions
About this article
Cite this article
van Geldorp, M.W.A., Heuvelman, H.J., Kappetein, A.P. et al. Quality of life among patients with severe aortic stenosis. Neth Heart J 21, 21–27 (2013). https://doi.org/10.1007/s12471-012-0364-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12471-012-0364-9